REN and aortic stenosis: Patients with both AS and T2DM are a specific group because renin-angiotensin system inhibitors, a powerful tool for cardioprotection and nephroprotection in T2DM, are perceived as relatively contraindicated in severe AS, due to the putative risk of hypotension.